This topic contains a solution. Click here to go to the answer

Author Question: The physician suspects that your patient may have 1-antitrypsin (-AT) deficiency. Which disease ... (Read 30 times)

Lisaclaire

  • Hero Member
  • *****
  • Posts: 569
The physician suspects that your patient may have 1-antitrypsin (-AT) deficiency. Which disease process would help to confirm this diagnosis?
 
  a. Panacinar emphysema
  b. Centrilobular emphysema
  c. Bronchiectasis
  d. Asthma

Question 2

A drug intended for therapy of congenital 1-antitrypsin deficiency is
 
  a. pulmozyme.
  b. pneumovax.
  c. prolastin.
  d. prednisone.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

heyhey123

  • Sr. Member
  • ****
  • Posts: 353
Answer to Question 1

ANS: A

Answer to Question 2

ANS: C




Lisaclaire

  • Member
  • Posts: 569
Reply 2 on: Jul 16, 2018
Wow, this really help


shailee

  • Member
  • Posts: 392
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

HIV testing reach is still limited. An estimated 40% of people with HIV (more than 14 million) remain undiagnosed and do not know their infection status.

Did you know?

The first-known contraceptive was crocodile dung, used in Egypt in 2000 BC. Condoms were also reportedly used, made of animal bladders or intestines.

Did you know?

Anesthesia awareness is a potentially disturbing adverse effect wherein patients who have been paralyzed with muscle relaxants may awaken. They may be aware of their surroundings but unable to communicate or move. Neurologic monitoring equipment that helps to more closely check the patient's anesthesia stages is now available to avoid the occurrence of anesthesia awareness.

Did you know?

Blastomycosis is often misdiagnosed, resulting in tragic outcomes. It is caused by a fungus living in moist soil, in wooded areas of the United States and Canada. If inhaled, the fungus can cause mild breathing problems that may worsen and cause serious illness and even death.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library